Fabiana Perna is an Oncology physician affiliated with Moffitt Cancer Center. OpenAlex indexes 209 publications with 6,913 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12902 Usf Magnolia Dr
Tampa, FL 336129416
Telephone
813-745-7365Provider last certified this registry record 25 Jul 2025.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JAZZ PHARMACEUTICALS INC.Program year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20234 payments
- Celgene CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Identifying cell surface targets for innovative immunotherapy of Multiple Myeloma
H. Lee Moffitt Cancer Ctr & Res Inst
FY2026$669,302R37CA276939 - Identifying cell surface targets for innovative immunotherapy of Multiple Myeloma
H. Lee Moffitt Cancer Ctr & Res Inst
FY2025$507,197R37CA276939 - Identifying cell surface targets for innovative immunotherapy of Multiple Myeloma
H. Lee Moffitt Cancer Ctr & Res Inst
FY2024$528,175R37CA276939
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
Clinical Cancer Research
2025 - Mapping the cancer surface proteome in search of target antigens for immunotherapy
Molecular Therapy
2024 - Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis
Nature Communications
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ignacio Wistuba, MD
Moffitt Cancer Center
Christine Chung, MD
Moffitt Cancer Center
Peter Forsyth, MD
Moffitt Cancer Center
Eric Haura, MD
Moffitt Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”